Chairman and Chief Executive Officer at Dilon Diagnostics ®
After more than 30 years in the healthcare field, Bob Moussa
has a long and successful record in the medical device industry.
He has held a number of senior positions at both Sherwood Medical Industries and Mallinckrodt Medical.
has extensive experience launching new products in the diagnostic, nuclear medicine and medical device markets.
Based upon existing clinical results, Moussa
believes that Dilon
will become the standard of care as an adjunct diagnostic tool in the diagnosis of early stage breast cancer.
feels this advanced technology is a major weapon in the battle against cancer and plans to make Dilon
the standard of care in the diagnostic field.
baccalaureate from the Collège du Sacre-Coeur, Quebec, and bachelor's of science in business administration from London University
has also completed executive seminars at the University of California at Berkeley, the Aspen Institute, the Wharton Executive School and the Center for Creative Leadership